Â¥
14.65
Nov 29
New Key Statistics Module, Z-Score and F-Score
SHSE:600535 Key Ratios
Market Cap ¥ M | 21,781.44 |
Enterprise Value ¥ M | 18,909.79 |
P/E(ttm) | 24.83 |
PE Ratio without NRI | 19.03 |
Forward PE Ratio | 16.51 |
Price/Book | 1.72 |
Price/Sales | 2.63 |
Price/Free Cash Flow | 11.04 |
Price/Owner Earnings | 55.23 |
Payout Ratio % | 0.43 |
Revenue (TTM) ¥ M | 8,565.00 |
EPS (TTM) ¥ | 0.59 |
Beneish M-Score | -3.22 |
10-y EBITDA Growth Rate % | -5.10 |
5-y EBITDA Growth Rate % | -17.20 |
y-y EBITDA Growth Rate % | -23.10 |
EV-to-EBIT | 17.36 |
EV-to-EBITDA | 17.36 |
PEG | -- |
Shares Outstanding M | 1,493.95 |
Net Margin (%) | 10.29 |
Operating Margin % | 16.64 |
Pre-tax Margin (%) | 11.84 |
Quick Ratio | 2.19 |
Current Ratio | 2.70 |
ROA % (ttm) | 5.10 |
ROE % (ttm) | 7.03 |
ROIC % (ttm) | 10.83 |
Dividend Yield % | 4.06 |
Altman Z-Score | 5.37 |
SHSE:600535 Number of Guru Trades
SHSE:600535 Volume of Guru Trades
Gurus Latest Trades with SHSE:600535
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600535 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tasly Pharmaceutical Group Co Ltd Insider Transactions
No Available Data